Cargando…

Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)

BACKGROUND: Mitogen-activated protein kinase-activated protein kinase 5 (MK5) is involved in one of the major signaling pathways in cells, the mitogen-activated protein kinase pathway. MK5 was discovered in 1998 by the groups of Houng Ni and Ligou New, and was found to be highly conserved throughout...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindin, Inger, Wuxiuer, Yimingjiang, Kufareva, Irina, Abagyan, Ruben, Moens, Ugo, Sylte, Ingebrigt, Ravna, Aina Westrheim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848485/
https://www.ncbi.nlm.nih.gov/pubmed/24034446
http://dx.doi.org/10.1186/1742-4682-10-56
_version_ 1782293765230166016
author Lindin, Inger
Wuxiuer, Yimingjiang
Kufareva, Irina
Abagyan, Ruben
Moens, Ugo
Sylte, Ingebrigt
Ravna, Aina Westrheim
author_facet Lindin, Inger
Wuxiuer, Yimingjiang
Kufareva, Irina
Abagyan, Ruben
Moens, Ugo
Sylte, Ingebrigt
Ravna, Aina Westrheim
author_sort Lindin, Inger
collection PubMed
description BACKGROUND: Mitogen-activated protein kinase-activated protein kinase 5 (MK5) is involved in one of the major signaling pathways in cells, the mitogen-activated protein kinase pathway. MK5 was discovered in 1998 by the groups of Houng Ni and Ligou New, and was found to be highly conserved throughout the vertebrates. Studies, both in vivo and in vitro, have shown that it is implicated in tumor suppression as well as tumor promotion, embryogenesis, anxiety, locomotion, cell motility and cell cycle regulation. METHODS: In order to obtain a molecular model of MK5 that can be used as a working tool for development of chemical probes, three MK5 models were constructed and refined based on three different known crystal structures of the closely related MKs; MK2 [PDB: 2OZA and PDB: 3M2W] and MK3 [PDB: 3FHR]. The main purpose of the present MK5 molecular modeling study was to identify the best suited template for making a MK5 model. The ability of the generated models to effectively discriminate between known inhibitors and decoys was analyzed using receiver operating characteristic (ROC) curves. RESULTS: According to the ROC curve analyzes, the refined model based on 3FHR was most effective in discrimination between known inhibitors and decoys. CONCLUSIONS: The 3FHR-based MK5 model may serve as a working tool for development of chemical probes using computer aided drug design. The biological function of MK5 still remains elusive, but its role as a possible drug target may be elucidated in the near future.
format Online
Article
Text
id pubmed-3848485
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38484852013-12-04 Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5) Lindin, Inger Wuxiuer, Yimingjiang Kufareva, Irina Abagyan, Ruben Moens, Ugo Sylte, Ingebrigt Ravna, Aina Westrheim Theor Biol Med Model Research BACKGROUND: Mitogen-activated protein kinase-activated protein kinase 5 (MK5) is involved in one of the major signaling pathways in cells, the mitogen-activated protein kinase pathway. MK5 was discovered in 1998 by the groups of Houng Ni and Ligou New, and was found to be highly conserved throughout the vertebrates. Studies, both in vivo and in vitro, have shown that it is implicated in tumor suppression as well as tumor promotion, embryogenesis, anxiety, locomotion, cell motility and cell cycle regulation. METHODS: In order to obtain a molecular model of MK5 that can be used as a working tool for development of chemical probes, three MK5 models were constructed and refined based on three different known crystal structures of the closely related MKs; MK2 [PDB: 2OZA and PDB: 3M2W] and MK3 [PDB: 3FHR]. The main purpose of the present MK5 molecular modeling study was to identify the best suited template for making a MK5 model. The ability of the generated models to effectively discriminate between known inhibitors and decoys was analyzed using receiver operating characteristic (ROC) curves. RESULTS: According to the ROC curve analyzes, the refined model based on 3FHR was most effective in discrimination between known inhibitors and decoys. CONCLUSIONS: The 3FHR-based MK5 model may serve as a working tool for development of chemical probes using computer aided drug design. The biological function of MK5 still remains elusive, but its role as a possible drug target may be elucidated in the near future. BioMed Central 2013-09-14 /pmc/articles/PMC3848485/ /pubmed/24034446 http://dx.doi.org/10.1186/1742-4682-10-56 Text en Copyright © 2013 Lindin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lindin, Inger
Wuxiuer, Yimingjiang
Kufareva, Irina
Abagyan, Ruben
Moens, Ugo
Sylte, Ingebrigt
Ravna, Aina Westrheim
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
title Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
title_full Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
title_fullStr Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
title_full_unstemmed Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
title_short Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
title_sort homology modeling and ligand docking of mitogen-activated protein kinase-activated protein kinase 5 (mk5)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848485/
https://www.ncbi.nlm.nih.gov/pubmed/24034446
http://dx.doi.org/10.1186/1742-4682-10-56
work_keys_str_mv AT lindininger homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5
AT wuxiueryimingjiang homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5
AT kufarevairina homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5
AT abagyanruben homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5
AT moensugo homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5
AT sylteingebrigt homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5
AT ravnaainawestrheim homologymodelingandliganddockingofmitogenactivatedproteinkinaseactivatedproteinkinase5mk5